291_parsons(2).pdf (57.25 kB)
What drives pharmaceutical innovation and knowledge exchange? A study supporting the use of Knowledge Management within the pharmaceutical industry
conference contributionposted on 2017-04-28, 09:45 authored by Thomas W. Parsons, Tom JacksonTom Jackson, Ray DawsonRay Dawson
Innovation is a key driver of the pharmaceutical company, from an initial discovery of a compound to the final development of a marketable and novel medicine, the web of processes to reach a viable end stage requires innovative behaviour backed by accurate knowledge. This paper analyses the use, importance and sources of knowledge within the drug development process and suggests that a pharmaceutical Knowledge Management strategy should not only address capturing the knowledge within the drug processes, but also the knowledge held within the social networks of the organisation.
- Business and Economics
Published inFirst International Conference on Organisational Learning, Knowledge and Capabilities, OLKC 2006 URL: http://www2.warwick.ac.uk/fac/soc/wbs/conf/olkc/archive/olkc1/papers/291_parsons.pdf
Pages? - ? (16)
CitationPARSONS, T.W., JACKSON, T. and DAWSON, R., 2006. What drives pharmaceutical innovation and knowledge exchange? A study supporting the use of Knowledge Management within the pharmaceutical industry. First International Conference on Organisational Learning, Knowledge and Capabilities, OLKC 2006, Coventry, 20th-22nd March, 16pp.
PublisherUniversity of Warwick
- VoR (Version of Record)
Publisher statementThis work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/
NotesThis is a conference paper.